The emerging COVID-19 pandemic led to a dramatic increase in global mortality and morbidity rates. As in most infections, fatal complications of coronavirus affliction are triggered by an untrammeled host inflammatory response. Cytokine storms created by high levels of interleukin and other cytokines elucidate the pathology of severe COVID-19. In this respect, repurposing drugs that are already available and might exhibit anti-inflammatory effects have received significant attention. With the in vitro and clinical investigation of several studies on the effect of antidepressants on COVID-19 prognosis, previous data suggest that selective serotonin reuptake inhibitors (SSRIs) might be the new hope for the early treatment of severely afflicted patients. SSRIs’ low cost and availability make them potentially eligible for COVID-19 repurposing. This review summarizes current achievements and literature about the connection between SSRIs administration and COVID-19 prognosis.
Background and aims: The current systematic review aimed to elucidate the effects of lipid variability on microvascular complication risk in diabetic patients. The lipid components studied were as follows: LDL, HDL, TG, Total Cholesterol, and Remnant Cholesterol. Method: We carried out a systematic search in multiple databases, including PubMed, Google Scholar, and Scopus, up to September 2022. Finally, after omitting the duplicates, 2724 studies were left, 104 related articles were extracted from the databases, and five articles were included in the study after screening the title, abstract and full text. Result: Five studies (4 cohorts and one cross-sectional) with a total population of 138664 were reviewed. These studies were done in China, Japan, Hong Kong, Taiwan, and Italy. The average age of the patients varied from 45 to 84 years. The follow-up duration of cohort studies ranged from 4 to 7 years. These studies have shown that higher LDL, HDL, and TG variability adversely affect microvascular complications, especially nephropathy and neuropathic complications. TG and LDL variability was associated with developing albuminuria and GFR decline. In another study, a lower HDL variation had a protective effect on microalbuminuria. In contrast, another study has shown no evidence of a relationship between lipid variation and microvascular complications such as retinopathy. Conclusion: The relationship between lipid variation (LDL, HDL, and TG) (adverse effects) on microvascular complications, especially nephropathy and neuropathic (and maybe not retinopathy), is proven. Physicians and health policymakers should be highly vigilant to lipid variation in a general population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.